| Literature DB >> 30862717 |
Suchitra Natarajan1, Kaitlyn M Foreman1, Michaela I Soriano1, Ninna S Rossen1,2, Hussein Shehade1, Daniel R Fregoso1, Joshua T Eggold1, Venkatesh Krishnan3, Oliver Dorigo3, Adam J Krieg4, Sarah C Heilshorn2, Subarna Sinha5, Katherine C Fuh6, Erinn B Rankin7,3.
Abstract
Peritoneal metastases are the leading cause of morbidity and mortality in high-grade serous ovarian cancer (HGSOC). Accumulating evidence suggests that mesothelial cells are an important component of the metastatic microenvironment in HGSOC. However, the mechanisms by which mesothelial cells promote metastasis are unclear. Here, we report that the HGSOC tumor-mesothelial niche was hypoxic, and hypoxic signaling enhanced collagen I deposition by mesothelial cells. Specifically, hypoxic signaling increased expression of lysyl oxidase (LOX) in mesothelial and ovarian cancer cells to promote collagen crosslinking and tumor cell invasion. The mesothelial niche was enriched with fibrillar collagen in human and murine omental metastases. Pharmacologic inhibition of LOX reduced tumor burden and collagen remodeling in murine omental metastases. These findings highlight an important role for hypoxia and mesothelial cells in the modification of the extracellular matrix and tumor invasion in HGSOC. SIGNIFICANCE: This study identifies HIF/LOX signaling as a potential therapeutic target to inhibit collagen remodeling and tumor progression in HGSOC.Graphical Abstract: http://cancerres.aacrjournals.org/content/canres/79/9/2271/F1.large.jpg. ©2019 American Association for Cancer Research.Entities:
Mesh:
Substances:
Year: 2019 PMID: 30862717 PMCID: PMC6822898 DOI: 10.1158/0008-5472.CAN-18-2616
Source DB: PubMed Journal: Cancer Res ISSN: 0008-5472 Impact factor: 12.701